Table 1.

Summary table of patient characteristics and healing progression

	Age/gender	Etiology of wound	Duration of wound (months)	Time to 100% granulation (days)	Time to STSG (days)	Time to complete healing (days)	Adjunctive therapies used
1	47/M	HIV neuropathy	3	13	29	60	Wound V.A.C., STSG
2	87/F	Venous leg ulcer	4	19	31	50	Wound V.A.C., STSG
3	52/F	Diabetic neuropathy	1	n/a	n/a	47	Regranex®

F, female; HIV, human immunodeficiency virus; M, male; STSG, split‐thickness skin graft.

n/a ‐ not applicable, did not undergo split thickness skin graft.